Giotta F - Search Results

1

Predicting of Sentinel Lymph Node Status in Breast Cancer Patients with Clinically Negative Nodes: A Validation Study.

Fanizzi A, Pomarico D, Paradiso A, Bove S, Diotaiuti S, Didonna V, Giotta F, La Forgia D, Latorre A, Pastena MI, Tamborra P, Zito A, Lorusso V, Massafra R. Fanizzi A, et al. Among authors: giotta f. Cancers (Basel). 2021 Jan 19;13(2):352. doi: 10.3390/cancers13020352. Cancers (Basel). 2021. PMID: 33477893 Free PMC article.

2

Management of toxicities associated with targeted therapies for HR-positive metastatic breast cancer: a multidisciplinary approach is the key to success.

Cazzaniga ME, Danesi R, Girmenia C, Invernizzi P, Elvevi A, Uguccioni M; NetworkER+. Cazzaniga ME, et al. Breast Cancer Res Treat. 2019 Aug;176(3):483-494. doi: 10.1007/s10549-019-05261-5. Epub 2019 May 7. Breast Cancer Res Treat. 2019. PMID: 31065872 Free PMC article. Review.

3

Liposomal-encapsulated doxorubicin plus cyclophosphamide as first-line therapy in metastatic breast cancer: a phase II multicentric study.

Giotta F, Lorusso V, Maiello E, Filippelli G, Valerio MR, Caruso M, Verderame F, Latorre A, Colucci G. Giotta F, et al. Ann Oncol. 2007 Jun;18 Suppl 6:vi66-9. doi: 10.1093/annonc/mdm228. Ann Oncol. 2007. PMID: 17591836 Free article. Clinical Trial.

4

Serotonin transporter polymorphism in major depressive disorder (MDD), psychiatric disorders, and in MDD in response to stressful life events: causes and treatment with antidepressant.

Daniele A, Divella R, Paradiso A, Mattioli V, Romito F, Giotta F, Casamassima P, Quaranta M. Daniele A, et al. Among authors: giotta f. In Vivo. 2011 Nov-Dec;25(6):895-901. In Vivo. 2011. PMID: 22021682 Review.

5

Angiogenetic axis angiopoietins/Tie2 and VEGF in familial breast cancer.

Danza K, Pilato B, Lacalamita R, Addati T, Giotta F, Bruno A, Paradiso A, Tommasi S. Danza K, et al. Among authors: giotta f. Eur J Hum Genet. 2013 Aug;21(8):824-30. doi: 10.1038/ejhg.2012.273. Epub 2012 Dec 12. Eur J Hum Genet. 2013. PMID: 23232696 Free PMC article.

6

Circulating levels of transforming growth factor-βeta (TGF-β) and chemokine (C-X-C motif) ligand-1 (CXCL1) as predictors of distant seeding of circulating tumor cells in patients with metastatic breast cancer.

Divella R, Daniele A, Savino E, Palma F, Bellizzi A, Giotta F, Simone G, Lioce M, Quaranta M, Paradiso A, Mazzocca A. Divella R, et al. Among authors: giotta f. Anticancer Res. 2013 Apr;33(4):1491-7. Anticancer Res. 2013. PMID: 23564790

7

Nuclear NHERF1 expression as a prognostic marker in breast cancer.

Paradiso A, Scarpi E, Malfettone A, Addati T, Giotta F, Simone G, Amadori D, Mangia A. Paradiso A, et al. Among authors: giotta f. Cell Death Dis. 2013 Nov 7;4(11):e904. doi: 10.1038/cddis.2013.439. Cell Death Dis. 2013. PMID: 24201803 Free PMC article.

8

Rapid tumor shrinkage with lapatinib plus capecitabine in a patient with massive liver involvement.

Giotta F, Latorre A, Cramarossa A, Simone G, Florio C, Oliva S, Lorusso V. Giotta F, et al. Tumori. 2013 Nov-Dec;99(6):278e-81e. doi: 10.1700/1390.15468. Tumori. 2013. PMID: 24503803

9

FISH testing of HER2 immunohistochemistry 1+ invasive breast cancer with unfavorable characteristics.

Petroni S, Caldarola L, Scamarcio R, Giotta F, Latorre A, Mangia A, Simone G. Petroni S, et al. Among authors: giotta f. Oncol Lett. 2016 Nov;12(5):3115-3122. doi: 10.3892/ol.2016.5125. Epub 2016 Sep 13. Oncol Lett. 2016. PMID: 27899970 Free PMC article.

10

Dose intensity and efficacy of the combination of everolimus and exemestane (EVE/EXE) in a real-world population of hormone receptor-positive (ER+/PgR+), HER2-negative advanced breast cancer (ABC) patients: a multicenter Italian experience.

Ciccarese M, Fabi A, Moscetti L, Cazzaniga ME, Petrucelli L, Forcignanò R, Lupo LI, De Matteis E, Chiuri VE, Cairo G, Febbraro A, Giordano G, Giampaglia M, Bilancia D, La Verde N, Maiello E, Morritti M, Giotta F, Lorusso V, Latorre A, Scavelli C, Romito S, Cusmai A, Palmiotti G, Surico G. Ciccarese M, et al. Among authors: giotta f. Breast Cancer Res Treat. 2017 Jun;163(3):587-594. doi: 10.1007/s10549-017-4213-9. Epub 2017 Mar 28. Breast Cancer Res Treat. 2017. PMID: 28353061

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

105 results

Search Page